STAT News

STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more

The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of upfront discounts, to certain providers

作者 STAT News

1 分钟阅读
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

相关洞察